Answers are grounded in this paper and cite their sources.
Real-world data shows favorable survival outcomes and local control in non-metastatic soft tissue sarcoma patients, implying effective management strategies.
patients, with a median dose of 50.4Gy.The local control rate at 3 years was 70 %.The 3 year overall survival (OS) and disease-free survival (DFS) of the non-metastatic patients were 85 % and 78%, respectively.Acute toxicities were predominantly Grade I-II, while Grade III-IV toxicities were observed in 10 % of patients.Conclusions: Radiotherapy in Ewings sarcoma remains an important modality for achieving local control, particularly in unresectable tumors or positive-margin disease.Acceptable toxicity and favorable survival outcomes highlight the importance of multidisciplinary management.
No takes yet. Share an insight, caveat, or question.
Afani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: